Overview

A Study to Find Out How Effective and Safe JNJ-88545223 is for the Treatment of Participants With Active Psoriatic Arthritis (a Long-term Inflammatory Arthritis)

Status:
NOT_YET_RECRUITING
Trial end date:
2027-08-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate how well the study drug JNJ-88545223 works compared with a placebo (an inactive substance) in adults with active psoriatic arthritis (PsA). The study aims to see whether treatment with JNJ-88545223 can help reduce the signs and symptoms of PsA and improve joint and skin health.
Phase:
PHASE2
Details
Lead Sponsor:
Janssen Research & Development, LLC